Tag Archives | biotech portfolios and ETFs

Sentiment Shift in a Wild Week: Biotech Bull Is Back-JUNO IPO Up 45%!… Update-1

Biotech Stocks Rally to New Highs After 4% Correction Buyers Are Bottom Feeding Energy Stocks NASDAQ at 4765 Just as the market appeared to be headed to another test of October lows, challenged by news on slowing global growth and a collapsing energy sector, FED Chair Janet Yellen calmed the markets saying it would be […]

Continue Reading 0

Fear Factor Is Back: Bearish Mood Hits Biotechs Update -1

December 18 “Don’t Fight the Fed”-cliches still work. Biotechs roar back near YTD highs. Yellen calms volatile markets. Healthcare Stocks Not Immune To Bearish Mood Crude Hits Lowest Level in Five Years Biotech stocks joined the market sell-off  again with all ETFs hit hard.The most volatile XBI was down 4.27% today and 3.55% over 5 […]

Continue Reading 0

Rayno Life Science Stocks: YTD Review Part 1-FBT Up 49%

Part 1 Biopharmaceutical Stocks-New Highs Were Hit on December 10 Five Straight Years of Gains in Biotech-the IBB is up 292% since Dec 18, 2009 Biotech stocks are following the long term seasonal bullish trend surging in Q4 and up about 49 % YTD. The easiest way to invest in the biotech market is with […]

Continue Reading 0

Energy Weakness Rolls Over To Biotech Stocks Update-1… 12/12

Crude Trade Roils Markets-But Biotech Is Still A Safe Haven Second Worst Week of the Year-Late Day Trading Hit By Selling As the market becomes more volatile we should look at how the energy trade is affecting other asset classes. Certainly materials and industrials are being hit over the past month. With respect to healthcare […]

Continue Reading 0

Biotech Stocks Hit By Profit Taking-More Volatility Lies Ahead…Update-1

Bounce Back Day 12/2/14      FBT up 1.5% to $102.33 Biotech players realized that news about China, energy and holiday shopping data do not affect their stocks. Our large cap biopharma portfolio went green helped by Biogen Idec (BIIB) up 6.43% on Phase 1a data for an Alzheimer Diseases drug! The AD drug got […]

Continue Reading